[시장보고서]세계의 심혈관 건강보조제 시장 : 보조제 유형별, 형태별, 유통별, 데모그래픽별, 국가별, 지역별

세계의 심혈관 건강보조제 시장 : 보조제 유형별, 형태별, 유통별, 데모그래픽별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Cardiovascular Health Supplements Market, By Supplement Type, By Form, By Distribution, By Demographics, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

상품코드 : 1555691

리서치사 : AnalystView Market Insights

발행일 : 2024년 08월

페이지 정보 : 영문 367 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,250

￦ 4,724,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650

￦ 6,759,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650

￦ 8,213,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

보고서 하이라이트

심혈관 건강보조제 시장 규모는 2023년 112억 3,423만 달러로 2024년부터 2032년까지 복합 연간 성장률(CAGR) 8.98%로 확대될 전망입니다.

심혈관 건강보조제 시장 : 시장 역학

심혈관 질환에 대한 세계의 인식과 유병률 증가는 심혈관 건강보조제 시장의 성장을 가속

심혈관 질환에 대한 세계 의식 증가와 그 유병률의 상승이 심혈관 건강보조제 수요를 크게 밀어 올리고 있습니다. 세계보건기구(WHO)에 따르면 심혈관질환은 세계 사망의 최상위이며 연간 약 1, 790만 명이 사망하고 있습니다. 이 우려할만한 통계는 오메가 3 지방산과 CoQ10과 같은 보조제의 사용을 포함한 예방 조치를 추진하기 위해 공공 및 민간 의료 기관을 추진하고 있습니다. 예를 들어, 미국 심장 협회는 심장에 좋은 라이프 스타일의 일부로 특정 영양 보조제를 도입하는 것을 권장하며 예방 의료에 대한 광범위한 동향을 반영합니다. 또한 CDC 보고서는 미국 성인의 약 절반이 일부 심혈관 질환을 앓고 있음을 강조하며 심장 질환과 관련된 위험 요소를 관리하고 완화하기위한 보조제를 포함한 개입이 필요합니다. 성이 더욱 강조됩니다.

심혈관 건강보조제 시장 : 주요 인사이트

우리의 리서치 애널리스트가 공유한 분석에 따르면 시장은 예측 기간 동안에 약 8.98%의 복합 연간 성장률(CAGR)로 매년 성장할 것으로 추정됩니다.

보조제 유형의 세분화에 근거하여, 오메가 3 지방산은 2023년에 가장 큰 시장 점유율을 보여줄 것으로 예상되었습니다.

형태별로는 2023년에 캡슐이 주요 유형이었습니다.

유통 부문별로 온라인 소매는 2023년의 주요 유형이었습니다.

지역별로는 북미가 2023년 수익으로 이끌었습니다.

심혈관 건강보조제 시장 : 세분화 분석 :

심혈관 건강보조제 시장은 보조제 유형, 형태, 유통, 인구 통계, 지역에 따라 분류됩니다.

시장은 보조제 유형에 근거하여 5개의 범주로 분할된다: 오메가 3 지방산, 코엔자임 Q10, 식이 섬유 보충교재, 식물 스테롤, 항산화제. 오메가 3 지방산은 심장 건강을 지원하는 강력한 증거로 심혈관 건강보조제 시장을 선도하고 코엔자임 Q10과 식물 스테롤이 인기 증가에 따라. 식이섬유 보조제와 산화방지제의 우선순위는 낮지만 필수적인 것은 아닙니다.

시장은 형태에 따라 다섯 가지 범주로 나뉩니다 : 정제, 캡슐, 분말, 액체 보조제, 구미. 캡슐과 정제는 편의성과 안정성으로 인해 심혈관 건강보조제 시장을 독점하고 있으며 유연한 복용이 가능한 분말이 뒤를 잇고 있습니다. 리퀴드 보조제가 인기를 끌고 있는 반면, 구미는 우선순위가 낮고 특정 소비자의 선호도에 호소하고 있습니다.

심혈관 건강보조제 시장 : 지리적 인사이트

북미가 시장을 독점하고 있지만, 이는 주로 높은 인지도, 선진 건강 관리 시스템, 예방 의료에 대한 강한 관심 때문입니다. 특히 미국이 이 지역을 선도하고 있으며, 인구의 상당 부분이 심장 건강 보조제를 정기적으로 이용하고 있습니다. 유럽이 이에 이어 독일이나 영국과 같은 국가에서는 고령화 사회와 심혈관 질환 증가를 배경으로 채용이 확대되고 있습니다. 아시아태평양에서는 특히 중국, 일본, 인도 등 국가에서 가처분 소득 증가, 도시화, 건강 의식 증가에 힘입어 시장이 급증하고 있습니다. 그러나 라틴아메리카와 아프리카와 같은 지역에서는 보조제에 대한 인식과 접근이 제한되어 시장 침투도가 여전히 낮아서 중요한 과제가되고 있습니다. 그럼에도 불구하고 이러한 지역은 의식과 경제 상황이 개선됨에 따라 시장 성장의 미개척 기회가되었습니다.

심혈관 건강보조제 시장 : 경쟁 구도:

주요 업계 참여 기업은 Abbott Laboratories, Amway, Bayer AG, Harvarife Nutrition과 같은 기존 기업을 포함합니다. 이 회사들은 제품 혁신에 주력하고 있으며 오메가 3 지방산, CoQ10, 식물 스테롤 등 과학적 뒷받침 성분을 도입하여 차별화를 도모하고 있습니다. 게다가 많은 기업들이 제품 포트폴리오를 확장하고 개별 건강 요구에 맞는 개별 보조제를 제공함으로써 보다 폭넓은 소비자층을 캡처하려고 합니다. 시장은 또한 독자적인 제제와 천연 성분으로 틈새 시장에 대응하는 소규모의 전문성이 높은 기업과의 경쟁도 치열합니다. 전략적 제휴, 합병, 인수는 각 회사가 시장에서의 존재감과 지리적 도달범위를 높이려고 하는 가운데 일반적으로 이루어지고 있습니다. 심각한 경쟁에도 불구하고 심장 건강 보조제에 대한 수요 증가는 신규 진출기업과 기존 기업 모두에게 충분한 기회를 계속 제공합니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 심혈관 건강보조제 업계

경쟁 대시보드
기업 프로파일
- Pfizer Inc.
- Nature's Bounty Co.
- Herbalife Nutrition Ltd.
- Amgen Inc.
- GNC Holdings, Inc.
- BASF SE
- Abbott Laboratories
- GlaxoSmithKline plc
- DSM Nutritional Products
- The Nature's Way Products, LLC
- Nutrilite(Amway)
- MegaFood(FoodState)
- Now Foods
- Solgar Inc.
- Blackmores Limited
- Thrive Market
- Others

제13장 애널리스트의 전방위 전망

BJH

영문 목차

영문목차

REPORT HIGHLIGHT

Cardiovascular Health Supplements Market size was valued at USD 11,234.23 Million in 2023, expanding at a CAGR of 8.98% from 2024 to 2032.

The Cardiovascular Health Supplements Market focuses on products aimed at supporting heart health through various nutritional formulations, including omega-3 fatty acids, CoQ10, and plant sterols. Rising awareness about cardiovascular diseases, coupled with increasing incidences of heart-related conditions due to lifestyle changes, has fueled demand for these supplements. Growing consumer inclination towards preventive healthcare and the ageing global population further intensify this trend. However, the market faces challenges like stringent regulatory requirements and skepticism regarding the efficacy of these supplements. Opportunities lie in developing innovative products, such as personalized supplements, and expanding distribution channels.

Cardiovascular Health Supplements Market- Market Dynamics

Increasing Global Awareness and Prevalence of Cardiovascular Diseases Propel Cardiovascular Health Supplements Market Growth

The growing global awareness of cardiovascular diseases, coupled with their rising prevalence, has significantly boosted the demand for cardiovascular health supplements. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for approximately 17.9 million deaths annually. This alarming statistic has driven both public and private health organizations to promote preventive measures, including the use of supplements like omega-3 fatty acids and CoQ10. For instance, the American Heart Association has recommended the inclusion of specific dietary supplements as part of a heart-healthy lifestyle, reflecting the broader trend toward preventive healthcare. Furthermore, a report from the CDC highlighted that nearly half of all adults in the United States have some form of cardiovascular disease, further underlining the critical need for interventions, including supplementation, to manage and reduce risk factors associated with heart conditions.

Cardiovascular Health Supplements Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.98% over the forecast period (2024-2032)

Based on Supplement Type segmentation, Omega-3 Fatty Acids was predicted to show maximum market share in the year 2023

Based on Form segmentation, Capsules was the leading type in 2023

Based on distribution segmentation, Online Retail was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Cardiovascular Health Supplements Market- Segmentation Analysis:

The Global Cardiovascular Health Supplements Market is segmented based on Supplement Type, Form, Distribution, Demographics, and Region.

The market is divided into five categories based on Supplement Type: Omega-3 Fatty Acids, Coenzyme Q10, Fiber Supplements, Plant Sterols, and Antioxidants. Omega-3 fatty acids lead the cardiovascular health supplement market due to their strong evidence in supporting heart health, followed by Coenzyme Q10 and Plant Sterols for their growing popularity. Fiber Supplements and Antioxidants rank lower in priority, yet remain essential.

The market is divided into five categories based on Form: Tablets, Capsules, Powders, Liquid Supplements, and Gummies. Capsules and Tablets dominate the Cardiovascular Health Supplements market due to their convenience and stability, followed by Powders for flexible dosing. Liquid Supplements are gaining traction, while Gummies, though less prioritized, appeal to specific consumer preferences.

Cardiovascular Health Supplements Market- Geographical Insights

North America dominates the market, largely due to high awareness levels, advanced healthcare systems, and a strong focus on preventive healthcare. The U.S., in particular, leads the region, with a substantial portion of the population regularly using heart health supplements. Europe follows closely, with countries like Germany and the UK witnessing growing adoption driven by an ageing population and increasing incidences of cardiovascular diseases. In the Asia-Pacific region, the market is expanding rapidly, fueled by rising disposable incomes, urbanization, and growing health consciousness, particularly in countries like China, Japan, and India. However, market penetration remains lower in regions like Latin America and Africa, where limited awareness and access to supplements are key challenges. Nonetheless, these regions present untapped opportunities for market growth as awareness and economic conditions improve.

Cardiovascular Health Supplements Market- Competitive Landscape:

Key industry participants include established companies like Abbott Laboratories, Amway, Bayer AG, and Herbalife Nutrition, which leverage strong brand recognition, extensive distribution networks, and robust research and development capabilities. These companies are focused on product innovation, often incorporating scientifically-backed ingredients such as omega-3 fatty acids, CoQ10, and plant sterols to differentiate their offerings. Additionally, many players are expanding their product portfolios to include personalized supplements tailored to individual health needs, thereby attracting a broader consumer base. The market also sees significant competition from smaller, specialized companies that cater to niche markets with unique formulations and natural ingredients. Strategic partnerships, mergers, and acquisitions are common as companies seek to enhance their market presence and geographic reach. Despite the intense competition, the growing demand for heart health supplements continues to provide ample opportunities for new entrants and existing players alike.

Recent Developments:

In June 2023, Healthycell launched Heart & Vascular Health, an ultra-absorbable gel supplement aimed at supporting normal cholesterol, triglyceride, and blood pressure levels. It combines plant-based ingredients and vitamins, offering an easy, drug-free heart health solution in a single gel pack.

In July 2023, UK-based Dr. Vegan launched two new supplements: HeartPro for cardiovascular support with plant sterols, and pH Hero for women's vaginal health with probiotics. The launch expands the brand's plant-based offerings to meet growing consumer demand for natural, ethical supplements.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.
Nature's Bounty Co.
Herbalife Nutrition Ltd.
Amgen Inc.
GNC Holdings, Inc.
BASF SE
Abbott Laboratories
GlaxoSmithKline plc
DSM Nutritional Products
The Nature's Way Products, LLC
Nutrilite (Amway)
MegaFood (FoodState)
Now Foods
Solgar Inc.
Blackmores Limited
Thrive Market
Others

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY SUPPLEMENT TYPE- MARKET ANALYSIS, 2019 - 2032

Omega-3 Fatty Acids
Coenzyme Q10
Fiber Supplements
Plant Sterols
Antioxidants

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY FORM- MARKET ANALYSIS, 2019 - 2032

Tablets
Capsules
Powders
Liquid Supplements
Gummies

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

Online Retail
Health Food Stores
Pharmacies
Supermarkets
Direct Sales

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY DEMOGRAPHICS- MARKET ANALYSIS, 2019 - 2032

Adults
Elderly
Children
Specific Health Conditions

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Cardiovascular Health Supplements Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cardiovascular Health Supplements Market Snippet by Supplement Type
- 2.1.2. Cardiovascular Health Supplements Market Snippet by Form
- 2.1.3. Cardiovascular Health Supplements Market Snippet by Distribution
- 2.1.4. Cardiovascular Health Supplements Market Snippet by Demographics
- 2.1.5. Cardiovascular Health Supplements Market Snippet by Country
- 2.1.6. Cardiovascular Health Supplements Market Snippet by Region
2.2. Competitive Insights

3. Cardiovascular Health Supplements Key Market Trends

3.1. Cardiovascular Health Supplements Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cardiovascular Health Supplements Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cardiovascular Health Supplements Market Opportunities
3.4. Cardiovascular Health Supplements Market Future Trends

4. Cardiovascular Health Supplements Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cardiovascular Health Supplements Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Cardiovascular Health Supplements Market Landscape

6.1. Cardiovascular Health Supplements Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cardiovascular Health Supplements Market - By Supplement Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Supplement Type, 2023 & 2032 (%)
- 7.1.2. Omega-3 Fatty Acids
- 7.1.3. Coenzyme Q10
- 7.1.4. Fiber Supplements
- 7.1.5. Plant Sterols
- 7.1.6. Antioxidants

8. Cardiovascular Health Supplements Market - By Form

8.1. Overview
- 8.1.1. Segment Share Analysis, By Form, 2023 & 2032 (%)
- 8.1.2. Tablets
- 8.1.3. Capsules
- 8.1.4. Powders
- 8.1.5. Liquid Supplements
- 8.1.6. Gummies

9. Cardiovascular Health Supplements Market - By Distribution

9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
- 9.1.2. Online Retail
- 9.1.3. Health Food Stores
- 9.1.4. Pharmacies
- 9.1.5. Supermarkets
- 9.1.6. Direct Sales

10. Cardiovascular Health Supplements Market - By Demographics

10.1. Overview
- 10.1.1. Segment Share Analysis, By Demographics, 2023 & 2032 (%)
- 10.1.2. Adults
- 10.1.3. Elderly
- 10.1.4. Children
- 10.1.5. Specific Health Conditions

11. Cardiovascular Health Supplements Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Cardiovascular Health Supplements Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Cardiovascular Health Supplements Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Cardiovascular Health Supplements Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Cardiovascular Health Supplements Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Cardiovascular Health Supplements Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cardiovascular Health Supplements Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. Pfizer Inc.
- 12.2.2. Nature's Bounty Co.
- 12.2.3. Herbalife Nutrition Ltd.
- 12.2.4. Amgen Inc.
- 12.2.5. GNC Holdings, Inc.
- 12.2.6. BASF SE
- 12.2.7. Abbott Laboratories
- 12.2.8. GlaxoSmithKline plc
- 12.2.9. DSM Nutritional Products
- 12.2.10. The Nature's Way Products, LLC
- 12.2.11. Nutrilite (Amway)
- 12.2.12. MegaFood (FoodState)
- 12.2.13. Now Foods
- 12.2.14. Solgar Inc.
- 12.2.15. Blackmores Limited
- 12.2.16. Thrive Market
- 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us